Peer-influenced content. Sources you trust. No registration required. This is HCN.
Medical Professionals Reference (MPR)
The Sonu Band, now FDA-cleared for children 12+, showed a -2.74 mean TNSS improvement with no adverse events in a 2-week study.
Allergy & Immunology July 3rd 2025
Consultant360
Combined omalizumab-OIT therapy demonstrated an impressive 50-percentage-point advantage over placebo in food challenge success rates for children with multiple food allergies.
Allergy & Immunology January 8th 2025
Conexiant
A longitudinal study demonstrates that early peanut introduction can reduce allergy risk by 81%, with protection persisting through early adolescence despite varying consumption patterns.
HealthDay
Up to 17% of infants develop milk protein allergy, making it one of the most prevalent gastrointestinal disorders in the first year of life.
Allergy & Immunology November 27th 2024
MD Newsline
Recent findings suggest that a slow up-dosing strategy in peanut oral immunotherapy for young children may offer a safer and more effective approach to managing peanut allergies.
Allergy & Immunology August 16th 2024
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS